drugset / Trial / NCT00174460

Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age

NCT00174460

Phase 2 Completed 33 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

Safety and efficacy of Somatropin will be evaluated in short children born with a list weight below 1500 g and that did not catch up to normal height at the age of 4.

Timeline

Start
2005-08
Primary completion
2008-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic

Indications

No indication recorded.